Request Call Back

Contact Us

Zevalin
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Did you or the injured person develop Stevens Johnson Syndrome (SJS)?

Did you or the injured person develop Toxic Epidermal
Necrolysis (TEN)?


Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Zevalin

Zevalin Side Effects Lawsuits | Side Effects: Fatal Skin Reaction, Erythema Multiforme, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN)
CLICK HERE TO DOWNLOAD OUR ZEVALIN INFORMATION PACKAGE

Zevalon Side Effects May Lead To Skin Disease Lawsuits

Zevalin | Lawsuits, Lawyers | Side Effects: Fatal Skin Reaction, Erythema Multiforme, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN)

Biogen Idec warned on October 28, 2005 that one of its drugs to treat non-Hodgkin's lymphoma, Zevalin (generic: ibritumomab tiuxetan), can cause severe and sometimes fatal skin reactions and death. A warning has been added to Zevalin’s label and a letter was sent to prescribing physicians. The alert and warning revision describes severe cutaneous or mucocutaneous reactions, some with fatal outcomes, that have been reported in association with the Zevalin therapeutic regimen in the post-marketing experience.  Zevalin's product label was changed to include a black-box warning about reports of erythema multiforme, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), bullous dermatitis, and exfoliative dermatitis in patients who received the Zevalin therapeutic regimen. Some of the cases resulted in death.

Because potentially fatal side effects have been connected with Zevalin during clinical trials, the drug is approved only for patients who have not responded to other treatments, according to an FDA paper. A Biogen Idec representative said the warnings being added to the Zevalin label are already on the Rituxan label. Zevalin is occasionally used on patients who don't respond to Biogen Idec's other lymphoma drug, Rituxan. Zevalin was developed by Idec Pharmaceuticals, who has since merged with Biogen, forming Biogen Idec.

Legal Help For Victims Affected By Zevalin

If you or a loved one took Zevalin and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us anytime at 1-800-YOURLAWYER (1-800-968-7529).



 

ZevalinRSS Feed

FDA and Biogen Idec Issue Drug Safety Alert Concerning Fatal Reactions to Cancer Drug, Zevalin

Oct 30, 2005 | www.newsinferno.com
Biogen Idec, the world’s fourth largest biopharmaceutical company, has notified healthcare professionals of a significant revision to BOXED WARNINGS, WARNINGS, and ADVERSE REACTIONS sections of the Prescribing Information for the cancer drug Zevalin. http://www.fda.gov/medwatch/safety/2005/safety05.htm#Zevalin The alert and warning revision (http://www.fda.gov/medwatch/safety/2005/ZevalinPI.pdf) describe severe cutaneous or mucocutaneous reactions, some with fatal outcome, that have been...

More Zevalin News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo